237 related articles for article (PubMed ID: 23837662)
1. Langerhans-type and monocyte-derived human dendritic cells have different susceptibilities to mRNA electroporation with distinct effects on maturation and activation: implications for immunogenicity in dendritic cell-based immunotherapy.
Chung DJ; Romano E; Pronschinske KB; Shyer JA; Mennecozzi M; St Angelo ET; Young JW
J Transl Med; 2013 Jul; 11():166. PubMed ID: 23837662
[TBL] [Abstract][Full Text] [Related]
2. Highly efficient gene delivery by mRNA electroporation in human hematopoietic cells: superiority to lipofection and passive pulsing of mRNA and to electroporation of plasmid cDNA for tumor antigen loading of dendritic cells.
Van Tendeloo VF; Ponsaerts P; Lardon F; Nijs G; Lenjou M; Van Broeckhoven C; Van Bockstaele DR; Berneman ZN
Blood; 2001 Jul; 98(1):49-56. PubMed ID: 11418462
[TBL] [Abstract][Full Text] [Related]
3. Mature human Langerhans cells derived from CD34+ hematopoietic progenitors stimulate greater cytolytic T lymphocyte activity in the absence of bioactive IL-12p70, by either single peptide presentation or cross-priming, than do dermal-interstitial or monocyte-derived dendritic cells.
Ratzinger G; Baggers J; de Cos MA; Yuan J; Dao T; Reagan JL; Münz C; Heller G; Young JW
J Immunol; 2004 Aug; 173(4):2780-91. PubMed ID: 15294997
[TBL] [Abstract][Full Text] [Related]
4. Human Langerhans cells use an IL-15R-α/IL-15/pSTAT5-dependent mechanism to break T-cell tolerance against the self-differentiation tumor antigen WT1.
Romano E; Cotari JW; Barreira da Silva R; Betts BC; Chung DJ; Avogadri F; Fink MJ; St Angelo ET; Mehrara B; Heller G; Münz C; Altan-Bonnet G; Young JW
Blood; 2012 May; 119(22):5182-90. PubMed ID: 22510877
[TBL] [Abstract][Full Text] [Related]
5. Electroporation of immature and mature dendritic cells: implications for dendritic cell-based vaccines.
Michiels A; Tuyaerts S; Bonehill A; Corthals J; Breckpot K; Heirman C; Van Meirvenne S; Dullaers M; Allard S; Brasseur F; van der Bruggen P; Thielemans K
Gene Ther; 2005 May; 12(9):772-82. PubMed ID: 15750615
[TBL] [Abstract][Full Text] [Related]
6. Enhanced dendritic cell antigen presentation in RNA-based immunotherapy.
Kalady MF; Onaitis MW; Padilla KM; Emani S; Tyler DS; Pruitt SK
J Surg Res; 2002 Jun; 105(1):17-24. PubMed ID: 12069496
[TBL] [Abstract][Full Text] [Related]
7. Short-term cultured, interleukin-15 differentiated dendritic cells have potent immunostimulatory properties.
Anguille S; Smits EL; Cools N; Goossens H; Berneman ZN; Van Tendeloo VF
J Transl Med; 2009 Dec; 7():109. PubMed ID: 20021667
[TBL] [Abstract][Full Text] [Related]
8. An accelerated, clinical-grade protocol to generate high yields of type 1-polarizing messenger RNA-loaded dendritic cells for cancer vaccination.
Brabants E; Heyns K; De Smet S; Devreker P; Ingels J; De Cabooter N; Debacker V; Dullaers M; VAN Meerbeeck JP; Vandekerckhove B; Vermaelen KY
Cytotherapy; 2018 Sep; 20(9):1164-1181. PubMed ID: 30122654
[TBL] [Abstract][Full Text] [Related]
9. Electroporated Antigen-Encoding mRNA Is Not a Danger Signal to Human Mature Monocyte-Derived Dendritic Cells.
Hoyer S; Gerer KF; Pfeiffer IA; Prommersberger S; Höfflin S; Jaitly T; Beltrame L; Cavalieri D; Schuler G; Vera J; Schaft N; Dörrie J
J Immunol Res; 2015; 2015():952184. PubMed ID: 26824052
[TBL] [Abstract][Full Text] [Related]
10. In vivo depletion of CD4+CD25+ regulatory T cells enhances the antigen-specific primary and memory CTL response elicited by mature mRNA-electroporated dendritic cells.
Van Meirvenne S; Dullaers M; Heirman C; Straetman L; Michiels A; Thielemans K
Mol Ther; 2005 Nov; 12(5):922-32. PubMed ID: 16257383
[TBL] [Abstract][Full Text] [Related]
11. Induction of Influenza Matrix Protein 1 and MelanA-specific T lymphocytes in vitro using mRNA-electroporated dendritic cells.
Tuyaerts S; Michiels A; Corthals J; Bonehill A; Heirman C; de Greef C; Noppe SM; Thielemans K
Cancer Gene Ther; 2003 Sep; 10(9):696-706. PubMed ID: 12944989
[TBL] [Abstract][Full Text] [Related]
12. Leukoreduction system chambers are an efficient, valid, and economic source of functional monocyte-derived dendritic cells and lymphocytes.
Pfeiffer IA; Zinser E; Strasser E; Stein MF; Dörrie J; Schaft N; Steinkasserer A; Knippertz I
Immunobiology; 2013 Nov; 218(11):1392-401. PubMed ID: 23932569
[TBL] [Abstract][Full Text] [Related]
13. Generation of an optimized polyvalent monocyte-derived dendritic cell vaccine by transfecting defined RNAs after rather than before maturation.
Schaft N; Dörrie J; Thumann P; Beck VE; Müller I; Schultz ES; Kämpgen E; Dieckmann D; Schuler G
J Immunol; 2005 Mar; 174(5):3087-97. PubMed ID: 15728524
[TBL] [Abstract][Full Text] [Related]
14. An improved protocol for generation of immuno-potent dendritic cells through direct electroporation of CD14+ monocytes.
Milano F; van Baal JW; Rygiel AM; Bergman JJ; Van Deventer SJ; Kapsenberg ML; Peppelenbosch MP; Krishnadath KK
J Immunol Methods; 2007 Apr; 321(1-2):94-106. PubMed ID: 17336322
[TBL] [Abstract][Full Text] [Related]
15. Differences in T-helper polarizing capability between human monocyte-derived dendritic cells and monocyte-derived Langerhans'-like cells.
Rajkovic I; Dragicevic A; Vasilijic S; Bozic B; Dzopalic T; Tomic S; Majstorovic I; Vucevic D; Djokic J; Balint B; Colic M
Immunology; 2011 Feb; 132(2):217-25. PubMed ID: 21039466
[TBL] [Abstract][Full Text] [Related]
16. Studies on mRNA electroporation of immature and mature dendritic cells: effects on their immunogenic potential.
Met O; Eriksen J; Svane IM
Mol Biotechnol; 2008 Oct; 40(2):151-60. PubMed ID: 18543130
[TBL] [Abstract][Full Text] [Related]
17. Comparison of DNA- and mRNA-transfected mouse dendritic cells as potential vaccines against the human papillomavirus type 16 associated oncoprotein E7.
Dell K; Klein C; Gissmann L
Antivir Ther; 2008; 13(4):495-509. PubMed ID: 18672528
[TBL] [Abstract][Full Text] [Related]
18. Messenger RNA electroporation of human monocytes, followed by rapid in vitro differentiation, leads to highly stimulatory antigen-loaded mature dendritic cells.
Ponsaerts P; Van den Bosch G; Cools N; Van Driessche A; Nijs G; Lenjou M; Lardon F; Van Broeckhoven C; Van Bockstaele DR; Berneman ZN; Van Tendeloo VF
J Immunol; 2002 Aug; 169(4):1669-75. PubMed ID: 12165485
[TBL] [Abstract][Full Text] [Related]
19. Induction of antigen-specific CD8+ cytotoxic T cells by dendritic cells co-electroporated with a dsRNA analogue and tumor antigen mRNA.
Michiels A; Breckpot K; Corthals J; Tuyaerts S; Bonehill A; Heirman C; Thielemans K; Aerts JL
Gene Ther; 2006 Jul; 13(13):1027-36. PubMed ID: 16511519
[TBL] [Abstract][Full Text] [Related]
20. Peptide-loaded Langerhans cells, despite increased IL15 secretion and T-cell activation in vitro, elicit antitumor T-cell responses comparable to peptide-loaded monocyte-derived dendritic cells in vivo.
Romano E; Rossi M; Ratzinger G; de Cos MA; Chung DJ; Panageas KS; Wolchok JD; Houghton AN; Chapman PB; Heller G; Yuan J; Young JW
Clin Cancer Res; 2011 Apr; 17(7):1984-97. PubMed ID: 21355077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
